Manher Joshi
Chief Medical Officer · RHYTHM PHARMACEUTICALS, INC.
Individual
- 2025
- Aug 18, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Manher Joshi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Kayden Lee - $8.90M in RYTM purchases and sales in the last 12 months
- Hunter C. Smith - $8.84M in RYTM purchases and sales in the last 12 months
- Yann Mazabraud - $6.62M in RYTM purchases and sales in the last 12 months
- David P. Meeker - $5.13M in RYTM purchases and sales in the last 12 months
- Lynn A. Tetrault - $3.71M in RYTM purchases and sales in the last 12 months
- Joseph Shulman - $3.67M in RYTM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Manher Joshi?
Manher Joshi is a corporate insider, tracked as Chief Medical Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Manher Joshi submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
